Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26684 | 1.00 | — | — | |
| SCHEMBL28745990 | 1.00 | GAA (0.50) | GAADGAT1ALDH1A1TSHRUSP2 | |
| Iodide SCHEMBL28618721 | 0.97 | — | — | |
| SCHEMBL2323786 | 0.97 | — | — | |
| Lithium SCHEMBL30387988 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL6253681 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL4434111 | 0.97 | — | — | |
| Phosphine SCHEMBL11162239 | 0.97 | — | — | |
| SCHEMBL6500325 | 0.97 | — | — | |
| SCHEMBL28869078 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118108709-B | Preparation method and application of target CDK19 radionuclide labeling reagent | 中国医学科学院放射医学研究所 | 2026-05-19 | — | — | CN | disclosed |
| CN-122055172-A | Chimeric radiopharmaceuticals targeting the proton-sensitive receptor GPR4 | 安菲利克斯股份公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-120129679-A | VHH antibody DOTA conjugates | 雅博得乐医疗公司 | 2025-06-10 | — | — | CN | disclosed |
| WO-2025087466-A2 | LIGAND COMPOUND OF QUINOLINE STRUCTURE, AND RADIOACTIVE OR NON-RADIOACTIVE MARKER THEREOF AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025087229-A1 | LIGAND COMPOUND OF QUINOLINE STRUCTURE, RADIOACTIVE OR NON-RADIOACTIVE MARKER, AND USE | 四川科伦博泰生物医药股份有限公司 | 2025-05-01 | — | — | WO | disclosed |
| CN-119684384-A | Nitroreductase response fluorescence and magnetic resonance bimodal probe NO designed based on gemcitabine prodrug2-Cy-Gxtb-Gd-Biotin and synthetic method and application thereof | 中国科学院精密测量科学与技术创新研究院 | 2025-03-25 | — | — | CN | disclosed |
| CN-115838393-B | Intermediate for FAPI synthesis and preparation method and application thereof | 烟台蓝纳成生物技术有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-110753558-A | Novel compounds and their therapeutic use | 森陶里治疗有限公司 | 2020-02-04 | — | — | CN | disclosed |